Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review.
Combemale L, Bohelay G, Sitbon IY, Ahouach B, Alexandre M, Martin A, Pascal F, Soued I, Doan S, Morin F, Grootenboer-Mignot S, Caux F, Prost-Squarcioni C, Le Roux-Villet C. Combemale L, et al. Among authors: soued i. Front Immunol. 2024 Apr 15;15:1243566. doi: 10.3389/fimmu.2024.1243566. eCollection 2024. Front Immunol. 2024. PMID: 38686381 Free PMC article.
Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, Caux F, Pascal F, Doan S, Brette MD, Soued I, Gabison É, Aucouturier F, Letestu R, Laroche L, Bachelez H. Le Roux-Villet C, et al. Among authors: soued i. Arch Dermatol. 2011 Jul;147(7):843-9. doi: 10.1001/archdermatol.2011.54. Epub 2011 Mar 21. Arch Dermatol. 2011. PMID: 21422323
Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.
Munyangango EM, Le Roux-Villet C, Doan S, Pascal F, Soued I, Alexandre M, Heller M, Lièvre N, Aucouturier F, Caux F, Laroche L, Prost-Squarcioni C. Munyangango EM, et al. Among authors: soued i. Br J Dermatol. 2013 Feb;168(2):381-90. doi: 10.1111/bjd.12041. Br J Dermatol. 2013. PMID: 22963186
Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
Alexandre M, Bohelay G, Gille T, Le Roux-Villet C, Soued I, Morin F, Caux F, Grootenboer-Mignot S, Prost-Squarcioni C. Alexandre M, et al. Among authors: soued i. Front Immunol. 2022 Apr 20;13:874108. doi: 10.3389/fimmu.2022.874108. eCollection 2022. Front Immunol. 2022. PMID: 35514989 Free PMC article.
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
Bohelay G, Alexandre M, Le Roux-Villet C, Sitbon I, Doan S, Soued I, Shourick J, Rousset L, Mellottee B, Heller M, Lièvre N, Zumelzu C, Morin F, Grootenboer-Mignot S, Gabison E, Caux F, Prost-Squarcioni C, Musette P. Bohelay G, et al. Among authors: soued i. Front Immunol. 2022 Jun 30;13:915205. doi: 10.3389/fimmu.2022.915205. eCollection 2022. Front Immunol. 2022. PMID: 35844526 Free PMC article.
Activity of apremilast in a patient with severe pemphigus vulgaris: case report.
Delvaux C, Bohelay G, Sitbon IY, Soued I, Alexandre M, Cucherousset J, Gilardin L, Diep A, Caux F, Le Roux-Villet C. Delvaux C, et al. Among authors: soued i. Front Immunol. 2024 Jun 25;15:1404185. doi: 10.3389/fimmu.2024.1404185. eCollection 2024. Front Immunol. 2024. PMID: 38983857 Free PMC article.